2-(4-((3S,5R)-3,5-dimethylpiperazin-1-yl)-2-methoxyphenylamino)-9-methyl-5H-benzo[d]pyrimido[4,5-f][1,3]diazepin-6(7H)-one

ID: ALA4792672

PubChem CID: 155804523

Max Phase: Preclinical

Molecular Formula: C25H29N7O2

Molecular Weight: 459.55

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(N2C[C@@H](C)N[C@@H](C)C2)ccc1Nc1ncc2c(n1)-c1ccc(C)cc1NC(=O)N2

Standard InChI:  InChI=1S/C25H29N7O2/c1-14-5-7-18-20(9-14)29-25(33)30-21-11-26-24(31-23(18)21)28-19-8-6-17(10-22(19)34-4)32-12-15(2)27-16(3)13-32/h5-11,15-16,27H,12-13H2,1-4H3,(H,26,28,31)(H2,29,30,33)/t15-,16+

Standard InChI Key:  YEUMCRKFUPOKOM-IYBDPMFKSA-N

Molfile:  

 
     RDKit          2D

 34 38  0  0  0  0  0  0  0  0999 V2000
   35.7734  -13.1452    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.7723  -13.9647    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4803  -14.3737    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.4785  -12.7363    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.1902  -13.9656    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.1871  -13.1416    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.8322  -12.6196    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   38.6400  -12.7948    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.0014  -13.5383    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   38.6492  -14.2886    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.8441  -14.4764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.6056  -15.2660    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.1712  -15.8686    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.9785  -15.6762    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.2132  -14.8869    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.1448  -12.1522    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   35.0642  -14.3728    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.0636  -15.1899    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3554  -15.5964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3544  -16.4129    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0624  -16.8228    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.7727  -16.4104    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.7702  -15.5953    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0628  -17.6400    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.3527  -18.0458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3511  -18.8594    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0573  -19.2714    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.7666  -18.8637    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.7697  -18.0439    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.5402  -16.2698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6485  -15.1865    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.6500  -14.3693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6421  -19.2657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4731  -19.2743    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  5  2  0
  6  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  5 11  1  0
  7  8  1  0
  8  9  1  0
 10  9  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  8 16  2  0
  2 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 21 24  1  0
 24 25  1  0
 24 29  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 14 30  1  0
 19 31  1  0
 31 32  1  0
 26 33  1  1
 28 34  1  1
M  END

Alternative Forms

  1. Parent:

    ALA4792672

    ---

Associated Targets(Human)

TNK2 Tclin Tyrosine kinase non-receptor protein 2 (2836 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

BaF3 (4657 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 459.55Molecular Weight (Monoisotopic): 459.2383AlogP: 4.35#Rotatable Bonds: 4
Polar Surface Area: 103.44Molecular Species: BASEHBA: 7HBD: 4
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 12.72CX Basic pKa: 9.08CX LogP: 4.13CX LogD: 2.46
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.46Np Likeness Score: -0.94

References

1. Li Z,Powell CE,Groendyke BJ,Gero TW,Feru F,Feutrill J,Chen B,Li B,Szabo H,Gray NS,Scott DA.  (2020)  Discovery of a series of benzopyrimidodiazepinone TNK2 inhibitors via scaffold morphing.,  30  (19): [PMID:32739400] [10.1016/j.bmcl.2020.127456]

Source